Consolidated Planning Corp’s Boston Scientific BSX Stock Holding History

Consolidated Planning Corp’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,851	Closed	-$2.18M	–	154
2025 Q4	$2.18M	Sell	22,851 -27,747	-55%	-$2.72M	0.22%	99
2025 Q3	$4.94M	Buy	50,598 +285	+0.6%	+$29.5K	0.52%	64
2025 Q2	$5.4M	Buy	50,313 +1,133	+2%	+$115K	0.68%	49
2025 Q1	$4.96M	Buy	49,180 +407	+0.8%	+$41K	0.68%	47
2024 Q4	$4.36M	Buy	48,773 +1,018	+2%	+$89.6K	0.59%	56
2024 Q3	$4M	Buy	47,755 +3,429	+8%	+$270K	0.6%	56
2024 Q2	$3.41M	Buy	+44,326	New	+$3.24M	0.56%	56
2021 Q4	–	Sell	-534	Closed	-$23K	–	116
2021 Q3	$23K	Buy	+534	New	+$23.6K	0.01%	236

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Consolidated Planning Corp's BSX Position: Q1 2026 in Review

Consolidated Planning Corp sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 22,851 shares — an estimated $2.18M sold.

Consolidated Planning Corp first reported a position in BSX in Q3 2021 and held it in 8 quarters. The position peaked at $5.4M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Consolidated Planning Corp reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Consolidated Planning Corp sold 22,851 Boston Scientific shares in Q1 2026, an estimated $2.18M.
Consolidated Planning Corp first reported a position in Boston Scientific in Q3 2021 and held it in 8 quarters.
Consolidated Planning Corp's Boston Scientific position peaked at $5.4M in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Consolidated Planning Corp's 13F filing for Q1 2026, filed 16 Apr 2026.